Thomas Kerr

37.5k total citations · 1 hit paper
725 papers, 28.1k citations indexed

About

Thomas Kerr is a scholar working on Epidemiology, Public Health, Environmental and Occupational Health and Infectious Diseases. According to data from OpenAlex, Thomas Kerr has authored 725 papers receiving a total of 28.1k indexed citations (citations by other indexed papers that have themselves been cited), including 623 papers in Epidemiology, 371 papers in Public Health, Environmental and Occupational Health and 260 papers in Infectious Diseases. Recurrent topics in Thomas Kerr's work include HIV, Drug Use, Sexual Risk (599 papers), Opioid Use Disorder Treatment (365 papers) and HIV/AIDS Research and Interventions (253 papers). Thomas Kerr is often cited by papers focused on HIV, Drug Use, Sexual Risk (599 papers), Opioid Use Disorder Treatment (365 papers) and HIV/AIDS Research and Interventions (253 papers). Thomas Kerr collaborates with scholars based in Canada, United States and Australia. Thomas Kerr's co-authors include Evan Wood, Julio Montaner, Mark Tyndall, Will Small, M‐J Milloy, Kate Shannon, Kathy Li, Ryan McNeil, Kanna Hayashi and Robert S. Hogg and has published in prestigious journals such as The Lancet, JAMA and SHILAP Revista de lepidopterología.

In The Last Decade

Thomas Kerr

714 papers receiving 27.0k citations

Hit Papers

Association of highly active antiretroviral therapy cover... 2010 2026 2015 2020 2010 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Kerr Canada 84 21.1k 11.8k 9.4k 6.9k 6.2k 725 28.1k
Evan Wood Canada 85 20.6k 1.0× 11.3k 1.0× 12.0k 1.3× 6.4k 0.9× 4.5k 0.7× 694 28.6k
Steffanie A. Strathdee United States 91 26.2k 1.2× 6.4k 0.5× 17.0k 1.8× 6.8k 1.0× 10.9k 1.8× 773 34.7k
Matthew Hickman United Kingdom 83 19.3k 0.9× 8.0k 0.7× 5.9k 0.6× 3.7k 0.5× 2.2k 0.3× 620 28.2k
Don C. Des Jarlais United States 73 16.1k 0.8× 5.0k 0.4× 9.8k 1.0× 5.2k 0.8× 3.5k 0.6× 525 21.6k
Mark Tyndall Canada 74 12.6k 0.6× 5.3k 0.5× 6.5k 0.7× 3.0k 0.4× 3.4k 0.6× 263 16.2k
Julio Montaner Canada 87 20.7k 1.0× 5.7k 0.5× 20.9k 2.2× 5.5k 0.8× 4.3k 0.7× 755 35.8k
Samuel R. Friedman United States 72 14.0k 0.7× 4.1k 0.4× 9.6k 1.0× 6.1k 0.9× 4.0k 0.6× 466 18.5k
Martin T. Schechter Canada 67 8.5k 0.4× 4.3k 0.4× 5.8k 0.6× 2.6k 0.4× 1.8k 0.3× 373 15.8k
Frederick L. Altice United States 60 10.4k 0.5× 3.3k 0.3× 9.4k 1.0× 3.5k 0.5× 3.0k 0.5× 463 15.5k
Tim Rhodes United Kingdom 60 10.3k 0.5× 3.1k 0.3× 5.8k 0.6× 3.2k 0.5× 4.1k 0.7× 264 13.2k

Countries citing papers authored by Thomas Kerr

Since Specialization
Citations

This map shows the geographic impact of Thomas Kerr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Kerr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Kerr more than expected).

Fields of papers citing papers by Thomas Kerr

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Kerr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Kerr. The network helps show where Thomas Kerr may publish in the future.

Co-authorship network of co-authors of Thomas Kerr

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Kerr. A scholar is included among the top collaborators of Thomas Kerr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Kerr. Thomas Kerr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Fleming, Taylor, Jade Boyd, Marilou Gagnon, Thomas Kerr, & Ryan McNeil. (2024). Using drugs alone in single room occupancy housing: Understanding environmental drivers of overdose risk. International Journal of Drug Policy. 128. 104444–104444. 6 indexed citations
4.
Kerr, Thomas, et al.. (2024). Revive and Survive: A Critical Lens on the Refusal of Care After Opioid Overdose. The American Journal of Bioethics. 24(5). 30–33.
5.
Zhu, David T., et al.. (2024). Supervised safe consumption sites — lessons and opportunities for North America. The Lancet Regional Health - Americas. 39. 100889–100889. 2 indexed citations
6.
Olding, Michelle, Jade Boyd, Thomas Kerr, & Ryan McNeil. (2023). “We just don’t have the space for it”: Geographies of survival and spatial triage in overdose prevention sites. Health & Place. 83. 103067–103067. 7 indexed citations
7.
Balneaves, Lynda G., et al.. (2023). Reasonable access: important characteristics and perceived quality of legal and illegal sources of cannabis for medical purposes in Canada. SHILAP Revista de lepidopterología. 5(1). 18–18. 1 indexed citations
8.
Cui, Zishan, Mohammad Karamouzian, Michael R. Law, et al.. (2023). The Impact of Longitudinal Substance Use Patterns on the Risk of Opioid Agonist Therapy Discontinuation: A Repeated Measures Latent Class Analysis. International Journal of Mental Health and Addiction. 22(6). 4004–4020. 3 indexed citations
9.
Karamouzian, Mohammad, Jane A. Buxton, Celestin Hategeka, et al.. (2022). Shifts in substance use patterns among a cohort of people who use opioids after delisting of OxyContin in BC, Canada: An interrupted time series study. International Journal of Drug Policy. 109. 103852–103852. 10 indexed citations
10.
Goodman, Ashley, et al.. (2021). "I Used to be Scared to Even Like Stand Beside Somebody Who Had It": HIV Risk Behaviours and Perceptions among Indigenous People Who Use Drugs. International Indigenous Policy Journal. 12(3). 1–21. 2 indexed citations
11.
Kerr, Thomas, et al.. (2021). Increasing Preference for Fentanyl among a Cohort of People who use Opioids in Vancouver, Canada, 2017-2018. Substance Abuse. 43(1). 458–464. 20 indexed citations
12.
Brar, Rupinder, Kora DeBeck, M‐J Milloy, et al.. (2020). Changes in drug use behaviors coinciding with the emergence of illicit fentanyl among people who use drugs in Vancouver, Canada. The American Journal of Drug and Alcohol Abuse. 46(5). 625–631. 14 indexed citations
13.
Hayashi, Kanna, M‐J Milloy, Evan Wood, et al.. (2018). Use of withdrawal management services among people who use illicit drugs in Vancouver, Canada. Substance Abuse Treatment Prevention and Policy. 13(1). 27–27. 12 indexed citations
14.
Richardson, Lindsey, Thomas Kerr, Jean Shoveller, et al.. (2018). A Longitudinal Analysis of Daily Pill Burden and Likelihood of Optimal Adherence to Antiretroviral Therapy Among People Living With HIV Who Use Drugs. Journal of Addiction Medicine. 12(4). 308–314. 16 indexed citations
16.
Strathdee, Steffanie A., Leo Beletsky, & Thomas Kerr. (2014). HIV, drugs and the legal environment. International Journal of Drug Policy. 26. S27–S32. 66 indexed citations
17.
Small, Will, Andrea Krüsi, Evan Wood, Julio Montaner, & Thomas Kerr. (2011). Street-level policing in the Downtown Eastside of Vancouver, Canada, during the 2010 winter Olympics. International Journal of Drug Policy. 23(2). 128–133. 11 indexed citations
18.
Johnston, Caitlin, Cody Callon, Kathy Li, Evan Wood, & Thomas Kerr. (2010). Offer of financial incentives for unprotected sex in the context of sex work. Drug and Alcohol Review. 29(2). 144–149. 24 indexed citations
19.
Wood, Evan, Mark Tyndall, Kathy Li, et al.. (2005). Do Supervised Injecting Facilities Attract Higher-Risk Injection Drug Users?. American Journal of Preventive Medicine. 29(2). 126–130. 104 indexed citations
20.
Kerr, Thomas, Evan Wood, Dan Small, Anita Palepu, & Mark Tyndall. (2003). Potential use of safer injecting facilities among injection drug users in Vancouver's Downtown Eastside.. PubMed. 169(8). 759–63. 88 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026